Physicochemical Characterization of In Vitro LDL Glycation and Its Inhibition by Ellagic Acid (EA): An In Vivo Approach to Inhibit Diabetes in Experimental Animals

Table 3

Effect of EA on FBS and HbA1c in diabetic rat model in vivo.

Groups	FBS (mg dL^-1)	HbA1c (%)
Group I control
Group II diabetic control
Group III diabetic + 10 mg EA
Group IV diabetic + 20 mg EA
% inhibition by 10 mg EA	28%	21%
% inhibition by 20 mg EA	37%	47%

Each value is the for five rats in each group. The values differ significantly with the diabetic group.